AIDS Journal

#publishing the latest ground breaking research on #HIV & #AIDS

3.1 #impactfactor

Account run by the publishing associate in London (not pictured here)

[AIDS Journal @AIDS_Journal]

This systematic review found a very high one year mortality among people with HIV in subsaharan Africa presenting with CD4 counts <200 cells/mm3, indicating the need for early treatment initiation and retention in care.

🔗 👉 https://t.co/h28X3xIiNG

#HIV #mortality

[S.Enf.Infecciosas HRUM @infeccHRUmalaga]

Hoy el #DrCastaño explicando trabajo @AIDS_Journal sobre #toxoplasmosis🎠🧠serie 63 pacientes con 79% supervivencia👏 y mortalidad sobre todo 1er año⚰️.Importancia del DIAGNÓSTICO PRECOZ #VIH ⏳🧪para evitar esta infección y #pronóstico y #manejo en 👉🏻🔗 🆓https://t.co/XErTKJwW9F

[AIDS Journal @AIDS_Journal]

This case-control study among adolescents with perinatally acquired HIV in Nigeria demonstrated that poor oral health correlates with diminished cognitive performance, supporting integration of oral health screening in HIV care.
🔗👉 https://t.co/fr0C1oCG6d

@stephshiau

[Hopkins Med News @HopkinsMedNews]

New @HopkinsMedicine study in @AIDS_Journal (https://t.co/8lhmo9u4c7) predicts #HIV transmission will rise in 30 states & DC if parts of Ryan White HIV/AIDS (@HivRyan) Program end. Program is major source of HIV/AIDS med care, treatment & support in U.S. @Hopkins_GIM @JHMed_ID

[AIDS Journal @AIDS_Journal]

This large CDC US study among persons initiating PrEP found that only a minority was tested for HIV before starting PrEP showing the need to strengthen education about the management guidelines to avoid careless use of this important prevention method.

🔗 https://t.co/1en5kLpi7L

[Waniska: The Indigenous Wellness and Healing Hub @waniskacentre]

A new paper published in @AIDS_Journal shares findings from @usask professor Dr. David Blackburn’s research!
Waniska joined the study to assist with Indigenous community engagement to ensure the voices of those with lived/living experience were heard.
https://t.co/bZhQRs668J

[AIDS Journal @AIDS_Journal]

🌟This significant modelling study shows how these programs are crucial to declines in new infections and highlights the importance of programs tailored to serve populations disproportionately affected by HIV, for lowering overall HIV incidence.🌟

[AIDS Journal @AIDS_Journal]

With HIV prevalence of around 25%, Eswatini was among the first countries to achieve the 95-95-95 treatment targets, with dedicated programs for key populations like female sex workers.

Read more on the impact of this achievement in this study below👇

🔗https://t.co/Bu7JOFQAdJ

[AIDS Journal @AIDS_Journal]

This US study found that higher use of non-ART medications among PLHIV is associated with poorer cognitive function, highlighting the need for strategies to manage polypharmacy among PLHIV.

https://t.co/xB34lN4nbQ

@YanxunXu

[AIDS Journal @AIDS_Journal]

During the early stages of the Covid-19 pandemic a substantial reduction in new HIV infections and diagnoses occurred among MSM in Australia, primarily due to a decrease in the number of sexual partners.

Read more in this latest study!

🔗👉 https://t.co/6JwdSdgxG0

[AIDS Journal @AIDS_Journal]

Check out this latest paper in @AIDS_Journal here!

🔗👉https://t.co/MDjulzxMvi

[TheBodyPro @BodyPROHIV]

New study published in @AIDS_Journal: shows switching to injectable cabotegravir/rilpivirine works even without genotypic resistance data. Both groups maintained >93% viral suppression with very low failure rates.
Read more ➡ https://t.co/peGezBRvMG

#HIVCare #InjectableART

[AIDS Journal @AIDS_Journal]

During the early stages of the Covid-19 pandemic a substantial reduction in new HIV infections and diagnoses occurred among MSM in Australia primarily due to a decrease in the number of sexual partners.

Check out this paper from our latest issue!

🔗👉 https://t.co/NYkQv2VsNJ

[AIDS Journal @AIDS_Journal]

@SESSTIM
@agenceANRS

[AIDS Journal @AIDS_Journal]

Although transgender women living with HIV in France have a high viral suppression rate, structural barriers such as difficulties obtaining health insurance and gender-concordant identity documents persist and may impede optimal health outcomes.

🔗👉 https://t.co/a1GGH7PFN1

[AIDS Journal @AIDS_Journal]

This study in a very large WHO database showed a consistently high in-hospital mortality risk among PLHIV compared with HIV-negative individuals during all SARS-CoV2 variant waves.

Visit the link below to read, it's Open Access!

🔗👉https://t.co/UUGOcnDWPy

[AIDS Journal @AIDS_Journal]

A new study from Canada shows that older people with HIV infection are at increased risk of frailty and falls related to inappropriately-prescribed medications, particularly the use of sedative and anti-cholinergic drugs.

Read here! 👇
🔗 https://t.co/5GD1kI21bY

[AIDS Journal @AIDS_Journal]

Congratulations to @durstenfeld at @DOM_UCLA and the team on this important paper!

@CNICSnetwork

[AIDS Journal @AIDS_Journal]

Authors show the PREVENT algorithm from the American Heart Association does not adequately predict #cardiovasculardisease risk in a large multicentre cohort of PWH in the USA & may lead to failure to prescribe statins to PWH unless guidelines change.

🔗 https://t.co/OBa3cbAcji

[AIDS Journal @AIDS_Journal]

Examining the epidemiology of Kaposi Sarcoma (KS) in the US between 1996 and 2016, authors found that the KS risk was still elevated among PWH in the current treatment era and that consistent HIV control impacts prognosis.

🔗👉 https://t.co/oXoTTU2qNo

@MoffittNews

[Weill Cornell Medicine Population Health Sciences @WCMPopHealthSci]

Opioid agonist treatment (OAT) can improve HIV outcomes for people with opioid use disorder. In @AIDS_Journal, @CzarinaBehrends and @BruceSchackman explain the urgent need to evaluate the true cost of providing OAT around the world: https://t.co/Ln3lwCu1OA